TGINSIGHT SIMILAR POSTS
Source channel @rt_fra · Post #40708 · May 6
🗣« D’abord, #Zelensky a quasiment rejeté l’initiative de Russie d'un cessez-le-feu pour le Jour de la Victoire mais ensuite il a recouru à une ruse tactique, déclarant une « trêve » pour la nuit du 5 au 6 mai » – Léonid Sloutsky, président de la commission des affaires internationales de la Douma, s’exprime sur le cessez-le-feu pour le Jour de la Victoire. « D’abord, Zelensky a quasiment rejeté l’initiative de Russie sur le cessez-le-feu pour le Jour de la Victoire mais ensuite il s’est décidé à une ruse tactique, déclarant une « trêve » dans la nuit du 5 au 6 mai. La raison est banale : un ego meurtri. Comme si Moscou et Washington avaient discuté de cette idée mais que personne ne s’était adressé officiellement à Kiev à ce sujet. […] En réalité, les néonazis ukrainiens n’ont besoin ni d’un cessez-le-feu ni de la paix. Zelensky veut jouer selon ses propres règles, en comptant sur des provocations, et fait le singe devant ses sponsors européens. » RT en français • Osez questionner !
Hashtags
Search: #biotechnology
@venturevillagewall · Post #3500 · 12/19/2024, 01:59 PM
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 12/20/2024, 09:33 AM
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 12/21/2024, 10:22 AM
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 12/20/2024, 09:34 AM
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 12/20/2024, 09:32 AM
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 12/21/2024, 10:22 AM
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences